Molecular modeling of the intestinal bile acid carrier: a comparative molecular field analysis study
- PMID: 9491350
- DOI: 10.1023/a:1007919704457
Molecular modeling of the intestinal bile acid carrier: a comparative molecular field analysis study
Abstract
A structure-binding activity relationship for the intestinal bile acid transporter has been developed using data from a series of bile acid analogs in a comparative molecular field analysis (CoMFA). The studied compounds consisted of a series of bile acid-peptide conjugates, with modifications at the 24 position of the cholic acid sterol nucleus, and compounds with slight modifications at the 3, 7, and 12 positions. For the CoMFA study, these compounds were divided into a training set and a test set, comprising 25 and 5 molecules, respectively. The best three-dimensional quantitative structure-activity relationship model found rationalizes the steric and electrostatic factors which modulate affinity to the bile acid carrier with a cross-validated, conventional and predictive r2 of 0.63, 0.96, and 0.69, respectively, indicating a good predictive model for carrier affinity. Binding is facilitated by positioning an electronegative moiety at the 24-27 position, and also by steric bulk at the end of the side chain. The model suggests substitutions at positions 3, 7, 12, and 24 that could lead to new substrates with reasonable affinity for the carrier.
Similar articles
-
Identification of a region of the ileal-type sodium/bile acid cotransporter interacting with a competitive bile acid transport inhibitor.Biochemistry. 2002 Dec 17;41(50):14916-24. doi: 10.1021/bi0205404. Biochemistry. 2002. PMID: 12475240
-
Use of the intestinal bile acid transporter for the uptake of cholic acid conjugates with HIV-1 protease inhibitory activity.Pharm Res. 1997 Feb;14(2):176-80. doi: 10.1023/a:1012044526054. Pharm Res. 1997. PMID: 9090705
-
NMR-based modeling and binding studies of a ternary complex between chicken liver bile acid binding protein and bile acids.Proteins. 2007 Oct 1;69(1):177-91. doi: 10.1002/prot.21517. Proteins. 2007. PMID: 17607743
-
A new era in bile acid transport pathophysiology.J Pediatr Gastroenterol Nutr. 1998 Feb;26(2):236-7. doi: 10.1097/00005176-199802000-00025. J Pediatr Gastroenterol Nutr. 1998. PMID: 9481648 Review. No abstract available.
-
[Physiopathology, diagnosis, and treatment of cholelithiasis--with special reference to hepato-intestinal circulation of bile acid].Nihon Naika Gakkai Zasshi. 2001 Mar 10;90(3):428-33. Nihon Naika Gakkai Zasshi. 2001. PMID: 11307530 Review. Japanese. No abstract available.
Cited by
-
Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): influence of steroidal hydroxylation pattern and C-24 conjugation.Pharm Res. 2006 Jul;23(7):1451-9. doi: 10.1007/s11095-006-0219-4. Epub 2006 Jun 21. Pharm Res. 2006. PMID: 16783481 Free PMC article.
-
Towards a new age of virtual ADME/TOX and multidimensional drug discovery.Mol Divers. 2002;5(4):255-75. doi: 10.1023/a:1021376212320. Mol Divers. 2002. PMID: 12549676 Review.
-
Influence of charge and steric bulk in the C-24 region on the interaction of bile acids with human apical sodium-dependent bile acid transporter.Mol Pharm. 2006 May-Jun;3(3):282-92. doi: 10.1021/mp0600135. Mol Pharm. 2006. PMID: 16749860 Free PMC article.
-
Role of the intestinal bile acid transporters in bile acid and drug disposition.Handb Exp Pharmacol. 2011;(201):169-203. doi: 10.1007/978-3-642-14541-4_4. Handb Exp Pharmacol. 2011. PMID: 21103970 Free PMC article. Review.
-
A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta.Pharm Res. 2002 Dec;19(12):1788-800. doi: 10.1023/a:1021429105173. Pharm Res. 2002. PMID: 12523656 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources